Enhanced dcik cell preparation method and cell preparation thereof

A cell preparation and enhanced technology, applied in animal cells, vertebrate cells, blood/immune system cells, etc., can solve the problems of TIL source difficulty, lack of antigen specificity, limited cell expansion ability, etc., to achieve safety guarantee , improved storage time, and high reliability

Active Publication Date: 2016-07-06
ANDERSON CELL BIOLOGY HUBEI
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But this cell's attack on malignant cells is as antigen-specific as CIK cells
When the cells are co-cultured with tumor-infiltrating lymphocytes (TIL) after being pulsed with tumor-associated antigens, the induced effector cells have the ability to specifically attack malignant cells, but the ability to expand the immune effector cells is limited. And the source of TIL is difficult

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enhanced dcik cell preparation method and cell preparation thereof
  • Enhanced dcik cell preparation method and cell preparation thereof
  • Enhanced dcik cell preparation method and cell preparation thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] A method for preparing enhanced DCIK cells, comprising the following steps:

[0039] 1) Collect the patient’s anticoagulant blood under sterile conditions, centrifuge at 1500rpm / min for 6 minutes to absorb the upper plasma, inactivate at 56°C for 30 minutes and centrifuge for later use, dilute the blood cell pellet with compound normal saline with the same volume as the blood cell pellet, and the specific gravity is 1.077 Human lymphocyte separation solution and diluted blood were added to the centrifuge tube at a ratio of 1:1.5, centrifuged at 2000rpm / min for 15 minutes, carefully extracted the white blood cell layer in the middle, washed twice with compound normal saline, and obtained peripheral blood mononuclear cells after low-speed centrifugation (PBMC);

[0040] 2) Peripheral blood mononuclear cells were isolated from the peripheral blood collected from the patient; they were placed in a blood-free medium to adjust the cell concentration to 3×10 6 / ml of mononucl...

Embodiment 2

[0060] A method for preparing enhanced DCIK cells, comprising the following steps:

[0061] 1) Collect the patient’s anticoagulant blood under sterile conditions, centrifuge at 1500rpm / min for 6 minutes to absorb the upper plasma, inactivate at 56°C for 30 minutes and centrifuge for later use, dilute the blood cell pellet with compound normal saline with the same volume as the blood cell pellet, and the specific gravity is 1.077 Human lymphocyte separation solution and diluted blood were added to the centrifuge tube at a ratio of 1:1.5, centrifuged at 2000rpm / min for 15 minutes, carefully extracted the white blood cell layer in the middle, washed twice with compound normal saline, and obtained peripheral blood mononuclear cells after low-speed centrifugation (PBMC);

[0062] 2) Peripheral blood mononuclear cells were isolated from the peripheral blood collected from the patient; they were placed in a blood-free medium to adjust the cell concentration to 3×10 6 / ml of mononucl...

Embodiment 3

[0067] A method for preparing enhanced DCIK cells, comprising the following steps:

[0068] 1) Collect the patient’s anticoagulant blood under sterile conditions, centrifuge at 1500rpm / min for 6 minutes to absorb the upper plasma, inactivate at 56°C for 30 minutes and centrifuge for later use, dilute the blood cell pellet with compound normal saline with the same volume as the blood cell pellet, and the specific gravity is 1.077 Human lymphocyte separation solution and diluted blood were added to the centrifuge tube at a ratio of 1:1.5, centrifuged at 2000rpm / min for 15 minutes, carefully extracted the white blood cell layer in the middle, washed twice with compound normal saline, and obtained peripheral blood mononuclear cells after low-speed centrifugation (PBMC);

[0069] 2) Peripheral blood mononuclear cells were isolated from the peripheral blood collected from the patient; they were placed in a blood-free medium to adjust the cell concentration to 3×10 6 / ml of mononuclea...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an enhanced DCIK (dendritic cell activated cytokine-induced killer) cellpreparation method and cell preparation. The method comprises the steps as follows: a PBMC (peripheral blood mononuclear cell) is separated from collectedperipheral blood of a patient; the PBMC is placed in a blood-free medium for culture to obtain nuclear cells with the concentration of 1-3*10<6> / ml, IFN-gamma (interferon-gamma), phytohemagglutinin and PGE2 (prostaglandin E2) are added, and the mixture is transferred into a culture flask or a culture bag to be cultured for 24 h; then a CD3 monoclonal antibody, IL-2 (interleukin-2), IL-1alpha, IL-4 and a GM-CSF (granulocyte-macrophage colony-stimulating factor) are added, the mixture is cultured for 3-5 days, the cell density is controlled in a range of 1-6*10<6> / ml, the mixture is cultured for 14-21 days continuously, and an enhanced CIK cell is obtained through centrifugal collection. The enhanced DCIK cell preparation comprises the enhanced DCIK cell, human blood albumin, the IL-2, amino acid, vitamins and inorganic salt. The preservation time of the DCIK cell preparation is substantially longer than those of preparations in previous patents and is prolonged to 36 hours from 6 hours under the room temperature condition. The preparation is higher in reliability in clinical applications, and the safety is effectively guaranteed.

Description

technical field [0001] The invention relates to the field of in vitro culture of immune cells, in particular to a method for preparing enhanced DCIK cells and a cell preparation. Background technique [0002] Adoptive cellular immunotherapy refers to a treatment method that directly kills tumor cells or viruses by infusing self or allogeneic specific and non-specific anti-tumor immune effector cells. Adoptive cellular immunotherapy has entered clinical application and has become the fourth major tumor treatment method after surgery, radiotherapy and chemotherapy. The types of such immune cells include lymphokine-activated killer cells (LAK), tumor infiltrating lymphocytes (TIL), cytotoxic lymphocytes (CTL), etc. Among many immune cells, dendritic cells (DC) The research and application of a new generation of tumor vaccines has become a hot spot in active immunotherapy research in recent years. In the body's immune response, DC is the most important antigen-presenting cell,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/0783A61K35/17A61P35/00
Inventor 许亮艾伟石纪刚柳海洋张辉
Owner ANDERSON CELL BIOLOGY HUBEI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap